Toxicologists Clash on Drug in Cosby Sex Assault Trial

After his first trial ended in a hung jury less than one year ago, Comedian Bill Cosby on Thursday was convicted of drugging and molesting a former Temple University athletics department employee in what Bloomb.....»»

Final summations are expected to be presented on Tuesday, after which the jury will begin deliberating Bill Cosby’s fate......»»

The amount of the settlement was made public in the first day of Cosby's retrial. As Bill Cosby's retrial got underway Monday, one new detail was revealed: the comedian paid accuser Andrea Constand $3.38 mill.....»»

Prosecutors opened Bill Cosby’s criminal trial outside Philadelphia on Monda.....»»

Lawyers for Mr. Cosby, now in prison for sexual assault, had asked the trial judge to overturn the jury’s verdict based on a number of grounds......»»

Putin made his first comments on the Iranian assault on Israel, urging all involved parties to exercise caution to avoid a significant regional clash read more.....»»

The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity. Latest Ratings for A.....»»

Shares of Myovant Sciences Ltd. were down 5.7% in premarket trading on Wednesday after the company told investors that the Food and Drug Administration had placed a partial clinical hold on a study assessing an experimental birth c.....»»

Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment .....»»

WASHINGTON – Children from 6 months up to 12 years old could soon start getting the Covid-19 vaccine in Phoenix as part of a trial of the drug’s effectiveness on young people. Drug-maker Moderna announced this week that Phoenix will be one of.....»»

ShaShares of Eli Lilly & Co. were down 5.2% in premarket trading on Monday, two days after the drug maker said additional clinical-trial data reinforced the role its experi.....»»

Pandion’s lead drug candidate, PT101, last month met its main goals of safety and tolerability in an early-stage trial in patients with autoimmune diseases......»»

Shares of GlaxoSmithKline were down 0.2% in trading on Thursday after the drug maker said its experimental monoclonal antibody treatment did not meet the primary endpoint in a mid-stage trial evaluating its use in hospitalized COVID-19 patients of all a.....»»

Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Immunovant lost nearly half their value on Tuesday after the company announced a voluntary pause of trials of its IMVT-1401 eye drug. A researcher works on a vaccin against the new coronavirus COVID-19 at .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

The drug slowed t.....»»

–Submitted investigational new drug (IND) application for a Phase 2 trial of EDP1815 for COVID-19; data readout expected during.....»»

Shares of Akebia Therapeutics Inc. gained 30% in premarket trading on.....»»